Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Moderna Shares Are Rising

Moderna Inc (NASDAQ:MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.

Shares of vaccine companies were otherwise trading lower during Tuesday's session. Over the past 4 trading sessions, Moderna's stock has fallen approximately 12.6% from the $175 level to the $152 level. 

See Also: Why DraftKings Shares Are Ripping Higher Today

Moderna is a commercial-stage biotech that was founded in 2010. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

Moderna has a 52-week high of $497.49 and a 52-week low of $117.34.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.